|
6051 |
Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
Enthalten in Critical care Bd. 14, 8.6.2010, Nr. 3, date:6.2010: 1-14
|
|
|
|
6052 |
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers
Enthalten in Breast cancer research Bd. 15, 23.9.2013, Nr. 5, date:10.2013: 1-13
|
|
|
|
6053 |
Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines
Enthalten in Journal of experimental & clinical cancer research Bd. 30, 16.4.2011, Nr. 1, date:12.2011: 1-7
|
|
|
|
6054 |
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Enthalten in CardioVascular and interventional radiology Bd. 33, 12.11.2009, Nr. 1, date:2.2010: 41-52
|
|
|
|
6055 |
Prost – aufs Herz!
Enthalten in CME Bd. 13, 18.5.2016, Nr. 5, date:3.2016: 32
|
|
|
|
6056 |
Prostatakrebs: DRU sagt bei niedrigen PSA-Werten wenig aus
Enthalten in Im Focus Onkologie Bd. 21, 5.2.2018, Nr. 1-2, date:2.2018: 70
|
|
|
|
6057 |
Prostatakrebs: PSA-Wert im mittleren Alter ist Risikomarker
Enthalten in MMW - Fortschritte der Medizin Bd. 166, 25.10.2024, Nr. 18, date:10.2024: 10-11
|
|
|
|
6058 |
Prostatakrebs: systematische Biopsie bei jungen Männern unverzichtbar
Enthalten in Uro-News Bd. 29, 3.9.2025, Nr. 9, date:9.2025: 39
|
|
|
|
6059 |
Prostatakrebs: Therapie zu wenig an Lebenserwartung orientiert
Enthalten in Im Focus Onkologie Bd. 28, 7.2.2025, Nr. 1, date:2.2025: 16-17
|
|
|
|
6060 |
Prostatakrebs: Zu viel Screening führt zu Übertherapie
Enthalten in Uro-News Bd. 28, 4.12.2024, Nr. 12, date:12.2024: 47
|
|
Administration
